STOCK MARKET BSE NSE

Bharat Biotech chairman Krishna Ella given 'Y' category central security cover

Ella, 52, is also the founder of the Hyderabad-based biotechnology company that is manufacturing the Covaxin vaccine approved by India for inoculation against COVID-19.

Published: 29th June 2021 08:45 PM  |   Last Updated: 29th June 2021 08:45 PM   |  A+A-

Krishna Ella, Chairman and MD, Bharat Biotech International Limited (Photo | Biotech4India, Twitter)

Krishna Ella, Chairman and MD, Bharat Biotech International Limited (Photo | Biotech4India, Twitter)

By PTI

NEW DELHI: Krishna Ella, the chairman of vaccine manufacturer Bharat Biotech, has recently been provided a "Y" category armed security cover by the Union government, officials said on Tuesday.

Ella, 52, is also the founder of the Hyderabad-based biotechnology company that is manufacturing the Covaxin vaccine approved by India for inoculation against COVID-19.

The company is also engaged in drug discovery, drug development, manufacturing various other vaccines, bio-therapeutics, pharmaceuticals and healthcare products.

The officials said Ella was provided the security cover of Central Industrial Security Force (CISF) armed commandos sometime ago given his current profile of spearheading the production of life-saving vaccines and other medical essentials.

About two-three commandos will accompany him whenever he travels to any part of the country under the "Y" category central cover, they said.

The premises of the Bharat Biotech International Limited (BBIL) in the Shameerpet area of Telangana's capital Hyderabad was recently accorded an armed protection cover by the same paramilitary force following approval by the Union home ministry.

"In light of the increased threat perception to the biotechnology company, BBIL is inherently vulnerable to threats from anti-nationals and saboteurs.

The CISF will provide a round-the-clock armed security cover to the facility in Hyderabad," a spokesperson of the force had then said.

In April, the Union government had similarly accorded a "Y" category security cover to Adar Poonawalla, the CEO and promoter of the Pune-based Serum Institute of India (SII) that manufactures the Covishield vaccine.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp